Latest Schedule 13G passive stakes

Morgan Stanley and its subsidiary Morgan Stanley Smith Barney LLC have filed a Schedule 13G, indicating they are no longer beneficial owners of more than five percent of Grove Collaborative Holdings, Inc.'s Class A Common Stock.

Morgan Stanley has updated its beneficial ownership filing for Cipher Digital Inc., reporting a significant holding of 7.4% as of September 30, 2026.

Morgan Stanley has updated its beneficial ownership filing for Cipher Digital Inc., reporting a significant holding of 7.4% as of September 30, 2026.

Manulife Financial Corporation and its subsidiary have filed an amendment to their Schedule 13G, reporting beneficial ownership of Riverview Bancorp Inc. common stock.

Manulife Financial Corporation and its subsidiary have filed an amendment to their Schedule 13G, reporting beneficial ownership of Riverview Bancorp Inc. common stock.

Glazer Capital, LLC and Paul J. Glazer have reported beneficial ownership of 5.3% of Priority Technology Holdings Inc.'s common stock.

Morgan Stanley and its subsidiary, Morgan Stanley Capital Services LLC, have updated their beneficial ownership filing for Xponential Fitness, Inc., reporting a combined stake of 7.0%.

Morgan Stanley and its subsidiary, Morgan Stanley Capital Services LLC, have updated their beneficial ownership filing for Xponential Fitness, Inc., reporting a combined stake of 7.0%.

TD Securities (USA) LLC has filed an amended Schedule 13G, reporting beneficial ownership of 292,156 shares of OneMedNet Corporation common stock issuable upon exercise of warrants.

Morgan Stanley has filed a Schedule 13G, disclosing beneficial ownership of 5.1% of Wolfspeed, Inc. common stock as of September 30, 2026.

Morgan Stanley has filed a Schedule 13G, disclosing beneficial ownership of 5.1% of Wolfspeed, Inc. common stock as of September 30, 2026.

Morgan Stanley and its subsidiary, Morgan Stanley Capital Services LLC, have filed an amendment to their Schedule 13G, reporting changes in their beneficial ownership of CEVA Inc. common stock.

Morgan Stanley and its subsidiary, Morgan Stanley Capital Services LLC, have filed an amendment to their Schedule 13G, reporting changes in their beneficial ownership of CEVA Inc. common stock.

Sculptor Capital LP and its affiliates have reported beneficial ownership of 1,000,000 Class A ordinary shares, representing 5.8% of the outstanding shares of Long Table Growth Corp.

Tanner Corredores de Bolsa S.A. has filed a Schedule 13G, reporting beneficial ownership of 812,500 ordinary shares, representing 6.4% of Ticketplus Ltd.

Morgan Stanley has filed an amendment to its Schedule 13G, reporting a beneficial ownership of Axogen, Inc. common stock below the 5% threshold.

Morgan Stanley has filed an amendment to its Schedule 13G, reporting a beneficial ownership of Axogen, Inc. common stock below the 5% threshold.

Shay Banon has filed an amendment to Schedule 13G, confirming beneficial ownership of 5,483,939 ordinary shares, representing 5.2% of Elastic N.V.

Morgan Stanley has updated its beneficial ownership filing for Agios Pharmaceuticals, Inc., reporting a 5.7% stake as of September 30, 2026.

Morgan Stanley has updated its beneficial ownership filing for Agios Pharmaceuticals, Inc., reporting a 5.7% stake as of September 30, 2026.

Georges-Olivier Reymond reports a 10.5% beneficial ownership stake in Pasqal Holding SA, including exercisable warrants.

Manulife Financial Corporation and its subsidiary have filed an amendment to their Schedule 13G, reporting their beneficial ownership of SB Financial Group, Inc. common stock.

Manulife Financial Corporation and its subsidiary have filed an amendment to their Schedule 13G, reporting their beneficial ownership of SB Financial Group, Inc. common stock.

Steven Schuurman and CMXI B.V. report beneficial ownership of 2,504,600 Elastic N.V. ordinary shares, representing 2.4% of the class.

Capital Research Global Investors has reported a beneficial ownership of 13,177,947 shares, representing 8.7% of the outstanding common stock of Stanley Black & Decker, Inc.

Capital Research Global Investors has disclosed a beneficial ownership of 7.0% in Vertex Pharmaceuticals Inc., holding 17,821,661 shares as of September 30, 2026.

Capital Research Global Investors has reported a beneficial ownership of 11,741,021 shares, representing 5.6% of DTE Energy's common stock, as of September 30, 2026.

Capital Research Global Investors has filed an amendment to its Schedule 13G, reporting beneficial ownership of 5.0% of Mondelez International, Inc. common stock as of September 30, 2026.

Capital Research Global Investors has reported a beneficial ownership of 6.7% in FTAI Aviation Ltd., signaling a notable investment position.

Capital Research Global Investors has updated its filing to report beneficial ownership of 10,141,445 shares, representing 3.7% of Ovintiv Inc.'s common stock.